郭 立人

Medicine & Life Sciences

1. Rectal Neoplasms 100%
2. Robotics 74%
3. glucose-regulated proteins 41%
4. Learning Curve 29%
5. Laparoscopy 24%
6. Hepatocellular Carcinoma 22%
7. Systematic Reviews 20%
8. Cell Movement 20%
9. Meta-Analysis 20%
10. Margins of Excision 19%
11. Fecal Incontinence 18%
12. Colonic Neoplasms 18%
13. Survivin 18%
14. Ergonomics 17%
15. Transanal Endoscopic Surgery 17%
16. Neoplasms 17%
17. Bevacizumab 16%
18. Colorectal Surgery 16%
19. Colorectal Neoplasms 16%
20. Surgeons 13%
21. gemcitabine 12%
22. Cetuximab 12%
23. Neoplasm Metastasis 12%
24. Inguinal Hernia 11%
25. alpha7 Nicotinic Acetylcholine Receptor 11%
26. Therapeutics 11%
27. Curcumin 11%
28. Fluorouracil 10%
29. Cisplatin 10%
30. Nicotine 9%
31. Fibronectins 9%
32. Proctectomy 9%
33. Length of Stay 8%
34. Stomach Neoplasms 8%
35. Recurrence 8%
36. Survival 8%
37. Herniorrhaphy 8%
38. Randomized Controlled Trials 8%
39. Anal Canal Carcinoma 8%
40. Pancreatic Neoplasms 8%
41. shikonin 8%
42. Disease-Free Survival 8%
43. Femoral Neuropathy 8%
44. Anecdotes 7%
45. Quality of Life 7%
46. Chemoradiotherapy 7%
47. Small Interfering RNA 7%
48. Neoadjuvant Therapy 7%
49. Hemorrhoidectomy 7%
50. Epithelial-Mesenchymal Transition 7%